The content on this site is intended for healthcare professionals only
Prof Lina Badimon speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the implications of platelet activation and blood coagulation in atherothrombosis.
Prof Badimon outlines the increased research in understanding the complications of platelet activation and blood coagulation in atherothrombosis.
Following this, she provides relevant advice for clinicians to take into everyday practise.
Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Encouraging results using mismatched unrelated donors in stem cell transplantation
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC
Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC
Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC
